FILING DEADLINE–Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BMRN, …

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

CEDARHURST, N.Y., Oct. 13, 2020 (GLOBE NEWSWIRE) — The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies.

BioMarin Pharmaceutical Inc. (BMRN)
Class Period: February 28, 2020 and August 18, 2020
Lead Plaintiff Motion Deadline: November 24, 2020
SECURITIES FRAUD
To learn more, visit https://kclasslaw.com/cases/securities/nasdaqgs-bmrn/

Peabody Energy Corp. (BTU)
Class Period: April 3, 2017 and October 28, 2019
Lead Plaintiff Motion Deadline: November 27, 2020
SECURITIES FRAUD
To learn more, visit https://kclasslaw.com/cases/securities/nyse-btu/

Credit Acceptance Corporation (CACC)
Class Period: November 1, 2019 and August 28, 2020
Lead Plaintiff Motion Deadline: December 1, 2020
SECURITIES FRAUD
To learn more, visit https://kclasslaw.com/cases/securities/nasdaqgs-cacc/

Shareholders who purchased shares in these companies during the dates listed are encouraged to contact us via the case links above,

Read More

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mesoblast Limited (“Mesoblast” or “the Company”) (NASDAQ: MESO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between April 16, 2019 and October 1, 2020, inclusive (the ”Class Period”), are encouraged to contact the firm before December 7, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected]

The class, in this case,

Read More

ROSEN, A LEADING NATIONAL FIRM, Announces Filing of Securities Class Action Lawsuit Against …

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

NEW YORK, Oct. 09, 2020 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Aurora had significantly overpaid for previous acquisitions and experienced degradation in certain assets, including its production facilities and

Read More

ROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Tactile …

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

NEW YORK, Oct. 09, 2020 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Tactile Systems Technology, Inc. (NASDAQ: TCMD) between May 7, 2018 and June 8, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Tactile investors under the federal securities laws.

To join the Tactile class action, go to http://www.rosenlegal.com/cases-register-1872.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

The complaint filed in this class action alleges that throughout the Class Period, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically,

Read More

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Peabody Energy Corporation (BTU) Investors

LOS ANGELES, Oct. 9, 2020 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Peabody Energy Corporation (“Peabody” or the “Company”) (NYSE: BTU) common stock between April 3, 2017 and October 28, 2019, inclusive (the “Class Period”).  Peabody investors have until November 27, 2020to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

On September 28, 2018, Peabody announced that it did “not expect any production from North Goonyella in the fourth quarter of 2018” due to a fire occurring within the mine.

On this news, the Company’s stock price fell $5.54, or over 13%, to close at $35.64 per share on September 28, 2018, thereby injuring investors.

Then, on February 6, 2019,

Read More

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Nikola Corporation (NKLA) Investors

LOS ANGELES, Oct. 8, 2020 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Nikola Corporation f/k/a VectoIQ Acquisition Corp. (“Nikola” or “VectoIQ” or the “Company”) (NASDAQ: NKLA) securities between March 3, 2020 and September 15, 2020, inclusive (the “Class Period”). Nikola investors have until November 16, 2020to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

On September 10, 2020, Hindenburg Research published a report entitled “Nikola: How to Parlay an Ocean of Lies into a Partnership with the Largest Auto OEM in America.” Therein, Hindenburg alleged that the Company’s founder, Trevor Milton, had misled partners into signing agreements by falsely claiming to have extensive proprietary technology. Among other things, the report claimed that Milton

Read More

ROSEN, NATIONAL TRIAL COUNSEL, Announces Filing of Securities Class Action Lawsuit Against …

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

NEW YORK, Oct. 06, 2020 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Golar LNG Limited (NASDAQ: GLNG) between April 30, 2020 and September 24, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Golar investors under the federal securities laws.

To join the Golar class action, go to http://www.rosenlegal.com/cases-register-1958.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

The complaint alleges throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) certain employees, including Hygo’s CEO, had bribed third parties, thereby violating anti-bribery policies; (2) as a result, the Company

Read More

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of NextCure, Inc. (NXTC) Investors

LOS ANGELES, Oct. 6, 2020 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired NextCure, Inc. (“NextCure” or the “Company”) (NASDAQ: NXTC): (a) securities between November 5, 2019 and July 14, 2020, inclusive (the “Class Period”); and/or (b) common stock pursuant or traceable to the Company’s November 2019 secondary public offering (“SPO” or the “Offering”). NextCure investors have until November 20, 2020 to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

In November 2019, NextCure completed its SPO, selling over 4 million shares at $36.75 per share.

On January 13, 2020, NextCure disclosed that Eli Lilly and Company had ended its collaboration agreement for the research and development of the Company’s leading product candidate, NC318, a

Read More